Cardiac Rehabilitation Market Size

Cardiac Rehabilitation Market Analysis

The Cardiac Rehabilitation Market size is estimated at USD 2.31 billion in 2024, and is expected to reach USD 2.96 billion by 2029, growing at a CAGR of 6% during the forecast period (2024-2029).

The specific characteristics of the COVID-19 pandemic made it challenging to identify whether and how people with heart disease could participate safely in cardiac rehabilitation and center-based exercise programs. According to the study published by the European Journal of Preventive Cardiology in August 2022, the pandemic had increased the demand for rehabilitation for COVID-19 patient groups who were critically ill with COVID-19 disease. Additionally, remote patient monitoring using implantable cardiac rehabilitation products was a safe alternative to in-person-only visits, which led to enhanced patient satisfaction and improved clinical outcomes. For instance, in February 2021, RhythMedix launched the next-generation cardiac monitor RhythmStar with built-in 4G cellular connectivity for arrhythmia detection. Therefore, there had been a greater need for cardiac rehabilitation, which was anticipated to have a beneficial impact on the market due to the COVID-19 pandemic. However, the market is returning to its pre-pandemic state due to decreased COVID-19 cases and the recovery of the healthcare sector with enhanced health access. The market will continue to rise steadily over the forecast period.

The cardiac rehabilitation market is primarily driven by increasing efforts to reduce heart diseases across the globe and the rising focus of the general population on health and fitness in developed countries. For instance, an article published by WHO in September 2022 called for a united effort to reduce mortality from cardiovascular diseases, a leading cause of death in the Southeast Asia Region, with 3.6 million lives lost every year. Through SEA HEARTS, the "WHO Southeast Asia HEARTS initiative," the WHO Southeast Asia Region intends to scale up and integrate ongoing activities in order to reduce mortality from cardiovascular diseases (CVDs) by one-third by 2030.

Additionally, according to the above source, representatives from Member countries, partners, academic institutions, and civil society organizations took part in the SEA HEARTS webinar, which examined strategies to speed up action against CVDs as part of a coordinated effort to promote cardiovascular health. Thus, such efforts are expected to reduce heart disease, leading to an increased demand for cardiac rehabilitation.

Furthermore, due to the demand for cardiac rehabilitation, market players are also focusing on product development and novel launches. For instance, in March 2022, MFine launched a Heart Rate Monitoring (HR) Tool on its app, which enables users to keep track of their heart rate without needing an additional device or any other app. Hence, as per the factors mentioned above, the cardiac rehabilitation market is anticipated to grow over the forecast period. However, a lack of knowledge in developing or underdeveloped nations is expected to impede market growth over the forecast period.